Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ceramide kinase (CERK) is an enzyme that specifically phosphorylates ceramide to generate ceramide 1-phosphate (C1P), a bioactive sphingolipid mediator involved in processes such as cell proliferation, survival, apoptosis, inflammation, and phagocytosis. CERK is categorized as a lipid kinase within the transferase family and is encoded by the CERK gene on human chromosome 22. Its enzymatic activity modulates the balance between pro-apoptotic ceramide and pro-survival C1P, thereby linking sphingolipid metabolism to signal transduction pathways controlling cellular responses to stress, inflammation, immune signaling, and oncogenesis. CERK has a broad substrate range for ceramides, shows key regulatory roles in immune cells and membrane dynamics, and is implicated in pathological conditions including cancer, inflammatory diseases, and neurodegeneration.
Enzyme inhibition (for CERK inhibitors) Modulation of ceramide-1-phosphate signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ceramide kinase (CERK).